Yu et al., 1994 - Google Patents
Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary reportYu et al., 1994
- Document ID
- 1956120271181593159
- Author
- Yu W
- Chang T
- Publication year
- Publication venue
- Artificial Cells, Blood Substitutes, and Biotechnology
External Links
Snippet
We used biodegradable polymers like polylactic acid, poly-isobutylcyanoacrylate and others to prepare nanocapsules containing hemoglobin. We prepared the optimal mean diameters of between 0.08 to 0.12 micron (80–120 nm). They are spherical and homogeneous. The …
- 108010054147 Hemoglobins 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report | |
| Yu et al. | Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization | |
| US4776991A (en) | Scaled-up production of liposome-encapsulated hemoglobin | |
| US4911929A (en) | Blood substitute comprising liposome-encapsulated hemoglobin | |
| US4652257A (en) | Magnetically-localizable, polymerized lipid vesicles and method of disrupting same | |
| US9415021B2 (en) | Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates | |
| CA1330937C (en) | Hemoglobin multiple emulsion | |
| US7498045B2 (en) | Biodegradable polymeric nanocapsules and uses thereof | |
| US4900556A (en) | System for delayed and pulsed release of biologically active substances | |
| USRE35338E (en) | Sustained release delivery of water soluble bio-molecules and drugs using phosphokipid-coated microcrystals, microdroplets and high-concentration lipsomes | |
| EP2560625B1 (en) | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same | |
| CN101239041B (en) | High molecule liposome and uses thereof | |
| Chang | Artificial cells in medicine and biotechnology | |
| US4873089A (en) | Proteoliposomes as drug carriers | |
| Prathyusha et al. | Liposomes as targetted drug delivery systems present and future prospectives: A review | |
| Patel et al. | An overview of resealed erythrocyte drug delivery | |
| Farmer et al. | Liposome-encapsulated hemoglobin: a synthetic red cell | |
| US5670173A (en) | Biodegradable polymer membrane containing hemoglobin for blood substitute | |
| Centis et al. | Enhancing oxygen solubility using hemoglobin-and perfluorocarbon-based carriers | |
| US6864094B2 (en) | Method of preserving oxygen infusions | |
| Vidal-Naquet et al. | Ltposome-Encapsulated Hemoglobin as an Artificial Red Blood Cell: Characterization and Scale-Up | |
| WO2004032970A2 (en) | Carriers attached to blood cells | |
| Shively | Multiple emulsions for the delivery of proteins | |
| Chang et al. | Blood substitutes based on modified hemoglobin and fluorochemicals | |
| Miller et al. | Hemodynamic effects of exchange transfusions with liposome-encapsulated hemoglobin |